Litigation Details for IN RE SUGAMMADEX (D.N.J. 2020)
✉ Email this page to a colleague
IN RE SUGAMMADEX (D.N.J. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-03-10 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-06-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | RE44,733 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IN RE SUGAMMADEX
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for IN RE SUGAMMADEX (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-11-03 | 119 | Letter | named inventor of the patent in suit, U.S. Patent No. RE44,733 (“the ’733 patent”). As we explain, yesterday… inventor’s testimony is relevant to issues in patent litigations. See Neupak, Inc. v. Ideal Mfg &… (and the other two named inventors of the ’733 patent) as having discoverable, relevant information.2…or agreements with Dr. Palin regarding the ’733 patent and this litigation and, if the parties are unable…2020 29 June 2023 2:20-cv-02576 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-06-13 | 418 | Opinion | reissued as U.S. Patent No. RE44,733 (the “RE’733 Patent”). The Patent and Trademark Office (the “PTO…U.S. Patent No. 6,670,340 on December 30, 2003, which was reissued as U.S. Patent No. RE44,733 patent…stating: U.S. Patent No. RE44,733 is a reissue of U.S. Patent No. 6,670,340 …induced during surgery. That patent, U.S. Patent No. 6,670,340 (the “’340 Patent”), was subsequently reissued…of a patent term extension for a reissued patent must be based on the date the reissued patent issued | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
